These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9476751)

  • 1. Depression in attention deficit hyperactivity disorder (ADHD) children: "true" depression or demoralization?
    Biederman J; Mick E; Faraone SV
    J Affect Disord; 1998 Jan; 47(1-3):113-22. PubMed ID: 9476751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the comorbidity between ADHD and major depression in adolescent and young adult females.
    Biederman J; Ball SW; Monuteaux MC; Mick E; Spencer TJ; McCREARY M; Cote M; Faraone SV
    J Am Acad Child Adolesc Psychiatry; 2008 Apr; 47(4):426-434. PubMed ID: 18388760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms.
    Milberger S; Biederman J; Faraone SV; Murphy J; Tsuang MT
    Am J Psychiatry; 1995 Dec; 152(12):1793-9. PubMed ID: 8526248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder.
    Sachs GS; Baldassano CF; Truman CJ; Guille C
    Am J Psychiatry; 2000 Mar; 157(3):466-8. PubMed ID: 10698829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.
    Wilens TE; Biederman J; Mick E; Faraone SV; Spencer T
    J Nerv Ment Dis; 1997 Aug; 185(8):475-82. PubMed ID: 9284860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled, blindly rated, direct-interview family study of a prepubertal and early-adolescent bipolar I disorder phenotype: morbid risk, age at onset, and comorbidity.
    Geller B; Tillman R; Bolhofner K; Zimerman B; Strauss NA; Kaufmann P
    Arch Gen Psychiatry; 2006 Oct; 63(10):1130-8. PubMed ID: 17015815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity of Attention Deficit Hyperactivity Disorder and Generalized Anxiety Disorder in children and adolescents.
    Melegari MG; Bruni O; Sacco R; Barni D; Sette S; Donfrancesco R
    Psychiatry Res; 2018 Dec; 270():780-785. PubMed ID: 30551325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do attention deficit hyperactivity disorder and major depression share familial risk factors?
    Faraone SV; Biederman J
    J Nerv Ment Dis; 1997 Sep; 185(9):533-41. PubMed ID: 9307614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.
    Biederman J; Faraone S; Milberger S; Guite J; Mick E; Chen L; Mennin D; Marrs A; Ouellette C; Moore P; Spencer T; Norman D; Wilens T; Kraus I; Perrin J
    Arch Gen Psychiatry; 1996 May; 53(5):437-46. PubMed ID: 8624187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study.
    Biederman J; Faraone S; Milberger S; Curtis S; Chen L; Marrs A; Ouellette C; Moore P; Spencer T
    J Am Acad Child Adolesc Psychiatry; 1996 Mar; 35(3):343-51. PubMed ID: 8714323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental pathways for different subtypes of early-onset bipolarity in youths.
    Masi G; Mucci M; Pfanner C; Berloffa S; Magazù A; Perugi G
    J Clin Psychiatry; 2012 Oct; 73(10):1335-41. PubMed ID: 23058936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of the aggression/anxiety-depression/attention child behavior checklist profile discriminates between different levels of deficits in emotional regulation in youth with attention-deficit hyperactivity disorder.
    Biederman J; Petty CR; Day H; Goldin RL; Spencer T; Faraone SV; Surman CB; Wozniak J
    J Dev Behav Pediatr; 2012 Apr; 33(3):236-43. PubMed ID: 22278125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
    Nierenberg AA; Miyahara S; Spencer T; Wisniewski SR; Otto MW; Simon N; Pollack MH; Ostacher MJ; Yan L; Siegel R; Sachs GS;
    Biol Psychiatry; 2005 Jun; 57(11):1467-73. PubMed ID: 15950022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of bipolar disorder and other comorbidity among youth with attention-deficit/hyperactivity disorder.
    Arnold LE; Van Meter AR; Fristad MA; Youngstrom EA; Birmaher BB; Findling RL; Horwitz S; Black SR
    J Child Psychol Psychiatry; 2020 Feb; 61(2):175-181. PubMed ID: 31523819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-morbidity of bipolar disorder in children and adolescents with attention deficit/hyperactivity disorder (ADHD) in an outpatient Turkish sample.
    Lus G; Mukaddes NM
    World J Biol Psychiatry; 2009; 10(4 Pt 2):488-94. PubMed ID: 19401947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actigraph measures discriminate pediatric bipolar disorder from attention-deficit/hyperactivity disorder and typically developing controls.
    Faedda GL; Ohashi K; Hernandez M; McGreenery CE; Grant MC; Baroni A; Polcari A; Teicher MH
    J Child Psychol Psychiatry; 2016 Jun; 57(6):706-16. PubMed ID: 26799153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating bipolar disorder in Turkish prepubertal children with attention-deficit hyperactivity disorder.
    Diler RS; Uguz S; Seydaoglu G; Erol N; Avci A
    Bipolar Disord; 2007 May; 9(3):243-51. PubMed ID: 17430299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
    Wilens TE; Biederman J; Prince J; Spencer TJ; Faraone SV; Warburton R; Schleifer D; Harding M; Linehan C; Geller D
    Am J Psychiatry; 1996 Sep; 153(9):1147-53. PubMed ID: 8780417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity.
    Biederman J; Milberger S; Faraone SV; Kiely K; Guite J; Mick E; Ablon S; Warburton R; Reed E
    Arch Gen Psychiatry; 1995 Jun; 52(6):464-70. PubMed ID: 7771916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.